These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10697747)

  • 21. Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice.
    Playford RJ; Marchbank T; Calnan DP; Calam J; Royston P; Batten JJ; Hansen HF
    Gastroenterology; 1995 Jan; 108(1):92-101. PubMed ID: 7806067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
    Bernkop-Schnürch A
    J Control Release; 1998 Mar; 52(1-2):1-16. PubMed ID: 9685931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent.
    Qi X; Chen H; Rui Y; Yang F; Ma N; Wu Z
    Int J Pharm; 2015 Jul; 489(1-2):210-7. PubMed ID: 25956047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucoadhesive polymers for buccal drug delivery.
    Laffleur F
    Drug Dev Ind Pharm; 2014 May; 40(5):591-8. PubMed ID: 24576266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro.
    Marschütz MK; Bernkop-Schnürch A
    Biomaterials; 2000 Jul; 21(14):1499-507. PubMed ID: 10872779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of prostaglandin E1 on the pepsin activities in gastric mucosa and juice.
    Ozeki T; Mizuno S; Ohuchi H; Iwaki K; Watanabe S; Ueda H; Kawahara H; Masuda H; Sanefugi H
    Br J Exp Pathol; 1987 Aug; 68(4):521-6. PubMed ID: 3115286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs.
    Wang J; Yadav V; Smart AL; Tajiri S; Basit AW
    Mol Pharm; 2015 Mar; 12(3):966-73. PubMed ID: 25612507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentration of trimipramine (Surmontil) and gastric secretion of acid and pepsin following peroral administration of the drug in healthy humans.
    Myren J; Schrumpf E; Bohman T; Skaug OE; Larsen S
    Scand J Gastroenterol; 1979; 14(2):237-40. PubMed ID: 373073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pepsin stabilizing factor (PSF) in the gastric mucosa and gastric juice in man and animal].
    Haendle H; Lorenz W; Sturm H; Reichel K; Feifel G; Werle E
    Langenbecks Arch Chir; 1968; 322():717-9. PubMed ID: 4921826
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
    Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
    Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
    Copeman M; Matuz J; Leonard AJ; Pearson JP; Dettmar PW; Allen A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S55-9. PubMed ID: 7881020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carvedilol-loaded mucoadhesive buccal tablets: influence of various mucoadhesive polymers on drug release behavior.
    Tamilvanan S; Bangale GS; Ananthi JJ; Sivakumar V; Vinothapooshan G; Palanivelu M; Viswanathan MB
    PDA J Pharm Sci Technol; 2009; 63(3):196-206. PubMed ID: 20069792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of controlled drug release systems based on thiolated polymers.
    Bernkop-Schnürch A; Scholler S; Biebel RG
    J Control Release; 2000 May; 66(1):39-48. PubMed ID: 10708877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
    Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
    Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucoadhesive polymers for oral transmucosal drug delivery: a review.
    Bagan J; Paderni C; Termine N; Campisi G; Lo Russo L; Compilato D; Di Fede O
    Curr Pharm Des; 2012; 18(34):5497-514. PubMed ID: 22632395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antacids and pepsin.
    Berstad A
    Scand J Gastroenterol Suppl; 1982; 75():13-5. PubMed ID: 6815782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of gastric environment on Helicobacter pylori adhesion to a mucoadhesive polymer.
    Nogueira F; Gonçalves IC; Martins MC
    Acta Biomater; 2013 Feb; 9(2):5208-15. PubMed ID: 22995406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enzyme-forming function of digestive glands after administration of polypeptide C, copepsidyl and panintestine].
    Storozhuk PG; Bykov IM; Malan'ina NS; Pavliuchenko II; Kolesnikov AN
    Ukr Biokhim Zh (1978); 1986; 58(5):77-80. PubMed ID: 3095969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of abomine, acidine-pepsin and acidine-mucosine on gastric secretion in dogs].
    Chemodanova AI
    Farmakol Toksikol; 1969; 32(6):696. PubMed ID: 4909668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.